DRG Fusion

DRG Fusion: Redefining commercial analytics for life sciences

Empowering life sciences & healthcare teams to solve commercial challenges and bring treatments to patients faster.

DRG Fusion is the most configurable, intelligent, and workflow-native analytics platform for commercial life sciences.

Powered by uniquely connected real-world data and an AI-driven experience, Fusion empowers you to analyze any disease, from any angle, and solve your most critical commercial challenges.

Request more information

The vision behind DRG Fusion

Hear from the Clarivate Vice President of Product Management as he shares the vision behind DRG Fusion — and how this game-changing platform delivers answers in seconds to questions that once took weeks to resolve.

Key use cases for commercial teams

Configurable modules powered by RWD connect patient, provider, and payer data to accelerate commercial execution.

Patient segmentation

Compare precision patient cohorts by geography and demographic attributes.

Patient journey

Track actionable transition points from PCP to specialist across lines of therapy – ‘best time to switch’.

Market access

Assess potential therapy adoption outcomes and prescribing impact through a payer dynamics lens.

Commercial targeting

Identify and operationalize target facilities or physicians driving key transitions and produce CRM-ready reports.

DRG Fusion in action: Case studies

Patient-led commercial targeting in Psoriatic Arthritis (Immunology)

A global biopharma company launching a new treatment for Psoriatic Arthritis (PsA) needs to improve the precision of its commercial strategy.

With DRG Fusion, the brand team shifts to a patient-led approach—starting from real-world patient journeys integrating longitudinal clinical and claims signals, and surfacing referral patterns that are usually invisible. This enables brand teams to see how patients actually move through care, and which providers drive access earlier.

 

Patient-Led Commercial Targeting in Multiple Sclerosis (Neurology)

A global biopharma company preparing to launch a new therapy for Relapsing Multiple Sclerosis (RMS) faces a targeting challenge.

With DRG Fusion, the company maps real-world patient journeys to uncover early points of care, referral flows, and missed opportunities. Unlike traditional models, Fusion integrates longitudinal data across specialties and reveals provider relationships that prescribing data alone cannot.

 

Delivering self-serve speed to insight in one place

Market challenges

  • Commercial teams lose time stitching together insights from too many systems.
  • Fragmented tools only solve parts of the problem, leaving blind spots.
  • Decisions get made without the right context, slowing down adoption and ROI.

DRG Fusion answers

  • Unified platform that connects claims, access, and patient journey data.
  • Configurable to your workflows, so insights align with your business rules.
  • AI-powered intelligence delivering rapid, self-serve insights.

Why now

  • Market dynamics shift too quickly for static tools.
  • Customers demand smarter, faster, and configurable solutions.
  • Built with the market, for the market to meet today’s urgency and tomorrow’s needs.

Fact sheet

Understand how patient transitions, payer dynamics, and prescriber behavior shape therapy adoption and brand performance.

Fact sheet
DRG Fusion
Ignite commercial success and improve patient outcomes with anew dynamic analytics product powered by real-world data

Request more information

Request more information